⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9142634 | 0.97 | MAPT (0.48) | — | |
| SCHEMBL5022714 | 0.97 | MAPT (0.48) | — | |
| SCHEMBL2686495 | 0.97 | — | — | |
| SCHEMBL6393139 | 0.97 | MAPT (0.48) | — | |
| SCHEMBL27629247 | 0.97 | MAPT (0.48) | — | |
| SCHEMBL5279629 | 0.91 | — | — | |
| SCHEMBL31119389 | 0.90 | MAPT (0.43) | — | |
| SCHEMBL1973936 | 0.78 | — | — | |
| SCHEMBL578477 | 0.77 | — | — | |
| Phosphine SCHEMBL27809472 | 0.77 | LCK (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0831770-B1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMA (US) | 2000-08-16 | — | — | EP | claimed |
| US-5874481-A | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-02-23 | — | — | US | claimed |
| CN-1192135-A | Continuous fluorochemical microdispersions for delivery of pharmaceutical agents | ALLIANCE PHARMA (US) | 1998-09-02 | — | — | CN | claimed |
| EP-0831770-A1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | claimed |
| US-5667809-A | Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-09-16 | — | — | US | claimed |
| WO-1996040053-A1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040052-A1 | FLUOROCHEMICAL SOLUTIONS FOR THE DELIVERY OF LIPOPHILIC PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| CN-116917029-A | Microparticles and microparticle dispersions | 国立大学法人东京大学 | 2023-10-20 | — | — | CN | disclosed |
| US-9554993-B2 | Pulmonary delivery particles comprising an active agent | NOVARTIS AG (CH) | 2017-01-31 | — | — | US | disclosed |
| US-20140234223-A1 | NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS | GUERBET (FR) | 2014-08-21 | — | — | US | disclosed |
| EP-2760480-A1 | NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS | Guerbet (FR) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013045504-A1 | PERFLUORINATED NANOEMULSIONS, METHOD FOR PREPARING SAME, AND USE THEREOF AS A CONTRAST AGENT | GUERBET (FR) | 2013-04-04 | — | — | WO | disclosed |
| WO-2013045333-A1 | NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS | GUERBET (FR) | 2013-04-04 | — | — | WO | disclosed |
| US-5455373-A | Method of producing perfluorocarbon halides | EXFLUOR RESEARCH CORPORATION (US) | 1995-10-03 | — | — | US | disclosed |
| EP-0647131-A1 | DERMATOLOGICAL AGENT FOR AIDING OXYGEN TRANSPORT IN THE SKIN. | LANCASTER GROUP AG (DE) | 1995-04-12 | — | — | EP | disclosed |
| EP-0647132-A1 | GALENIC COMPOSITION FOR TOPICAL USE. | LANCASTER GROUP AG (DE) | 1995-04-12 | — | — | EP | disclosed |
| EP-0647129-A1 | TOPICAL APPLICATION COMPOSITION. | LANCASTER GROUP AG (DE) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994000097-A1 | TOPICAL APPLICATION COMPOSITION | LANCASTER GROUP AG (DE) | 1994-01-06 | — | — | WO | disclosed |
| WO-1994000109-A1 | DERMATOLOGICAL AGENT FOR AIDING OXYGEN TRANSPORT IN THE SKIN | LANCASTER GROUP AG (DE) | 1994-01-06 | — | — | WO | disclosed |
| WO-1994000110-A1 | GALENIC COMPOSITION FOR TOPICAL USE | LANCASTER GROUP AG (DE) | 1994-01-06 | — | — | WO | disclosed |